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Abstract
During neuromuscular synaptogenesis, neurally released agrin induces aggregation and tyrosine
phosphorylation of acetylcholine receptors (AChRs) by acting through both the receptor tyrosine kinase
MuSK (muscle-specific kinase) and the AChR-associated protein, rapsyn. To elucidate this signaling
mechanism, we examined tyrosine phosphorylation of AChR-associated proteins, particularly
addressing whether agrin activates Src family kinases bound to the AChR. In C2 myotubes, agrin
induced tyrosine phosphorylation of these kinases, of AChR-bound MuSK, and of the AChR beta and
delta subunits, as observed in phosphotyrosine immunoblotting experiments. Kinase assays revealed that
the activity of AChR-associated Src kinases was increased by agrin, whereas phosphorylation of the
total cellular kinase pool was unaffected. In both rapsyn-deficient myotubes and staurosporine-treated
C2 myotubes, where AChRs are not clustered, agrin activated MuSK but did not cause either Src family
or AChR phosphorylation. In S27 mutant myotubes, which fail to aggregate AChRs, no agrin-induced
phosphorylation of AChR-bound Src kinases, MuSK, or AChRs was observed. These results
demonstrate first that agrin leads to phosphorylation and activation of AChR-associated Src-related
kinases, which requires rapsyn, occurs downstream of MuSK, and causes AChR phosphorylation.
Second, this activation intimately correlates with AChR clustering, suggesting that these kinases may
play a role in agrin-induced AChR aggregation by forming an AChR-bound signaling cascade.
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During neuromuscular synaptogenesis, neurally re-
leased agrin induces aggregation and tyrosine phospho-
rylation of acetylcholine receptors (AChRs) by acting
through both the receptor tyrosine kinase MuSK (mus-
cle-specific kinase) and the AChR-associated protein,
rapsyn. To elucidate this signaling mechanism, we ex-
amined tyrosine phosphorylation of AChR-associated
proteins, particularly addressing whether agrin acti-
vates Src family kinases bound to the AChR. In C2 myo-
tubes, agrin induced tyrosine phosphorylation of these
kinases, of AChR-bound MuSK, and of the AChR b and d
subunits, as observed in phosphotyrosine immunoblot-
ting experiments. Kinase assays revealed that the activ-
ity of AChR-associated Src kinases was increased by
agrin, whereas phosphorylation of the total cellular ki-
nase pool was unaffected. In both rapsyn-deficient myo-
tubes and staurosporine-treated C2 myotubes, where
AChRs are not clustered, agrin activated MuSK but did
not cause either Src family or AChR phosphorylation. In
S27 mutant myotubes, which fail to aggregate AChRs, no
agrin-induced phosphorylation of AChR-bound Src ki-
nases, MuSK, or AChRs was observed. These results
demonstrate first that agrin leads to phosphorylation
and activation of AChR-associated Src-related kinases,
which requires rapsyn, occurs downstream of MuSK,
and causes AChR phosphorylation. Second, this activa-
tion intimately correlates with AChR clustering, sug-
gesting that these kinases may play a role in agrin-
induced AChR aggregation by forming an AChR-bound
signaling cascade.
A common feature of most synapses is the local accumulation
of proteins regulating synaptic responses in the postsynap-
tic membrane. At the neuromuscular junction, a model system
for synaptogenesis, aggregation of acetylcholine receptors
(AChRs)1 is an early sign of postsynaptic differentiation during
development and occurs at sites of nerve-muscle contact (1, 2).
Clusters of AChRs and further synaptic components are in-
duced by neurally released agrin, an essential factor for syn-
aptogenesis (3). Accordingly, mice deficient for agrin lack dif-
ferentiated synapses and nerve-associated clusters of
postsynaptic proteins (4). Neurons or recombinant agrin induce
aggregation of AChRs and other muscle components when
added to cultured myotubes (5, 6), a process that mimics events
at developing endplates, as it is blocked by antibodies specific
for nerve-released agrin (7).
Little is known about the signaling pathway of agrin, al-
though a muscle-specific kinase, MuSK, is part of the agrin
receptor (8, 9), and proteoglycans are thought to play an acces-
sory role in presenting agrin to its receptor (10). Agrin causes
tyrosine phosphorylation of MuSK, and this kinase is essential
for postsynaptic specialization, as shown in MuSK-deficient
mice, in which the phenotype is similar to agrin2/2 animals
(11). Furthermore, myotubes lacking MuSK fail to respond to
agrin (9, 11). Agrin also causes tyrosine phosphorylation of the
b subunit of the AChR, which may play a role in AChR clus-
tering because, among other observations, the kinase inhibitors
herbimycin and staurosporine block both AChR b phosphoryl-
ation and AChR clustering (12, 13). However, mutant AChRs,
lacking cytoplasmic tyrosine residues in their b subunits, can
still be recruited into clusters upon expression in myotubes,
which also express wild-type AChRs (14). In addition, it has
been shown that AChR tyrosine phosphorylation is accompa-
nied by a change in receptor desensitization by cholinergic
ligands (15).
One protein involved in agrin signaling downstream of
MuSK is rapsyn, a 43-kDa protein closely associated with
AChRs (16, 17). Rapsyn2/2 mice lack aggregates of AChRs
and other postsynaptic proteins, and their cultured myotubes
fail to form agrin-induced AChR clusters, illustrating the im-
portance of rapsyn for postsynaptic organization (18). Further-
more, rapsyn causes aggregation of AChRs upon expression in
fibroblasts and is necessary for agrin-induced AChR b phos-
phorylation in myotubes (19, 20). MuSK, however, is still acti-
vated by agrin and localized at mutant endplates of rapsyn-
deficient animals, suggesting that MuSK forms a primary
synaptic scaffold to which rapsyn recruits AChRs and further
components of the postsynaptic apparatus (20, 21).
The individual steps of this postsynaptic assembly, in par-
ticular, the agrin signaling events downstream of MuSK, still
remain largely unknown. Myotubes contain preassembled
AChR protein complexes in which, independently of agrin,
AChRs are associated with several muscle proteins, including
rapsyn, MuSK, and Src-related kinases (21). Agrin selectively
increases, in a rapsyn-dependent way, the association between
AChRs and MuSK, suggesting that agrin causes a link of these
preassembled AChR protein complexes with the MuSK pri-
mary synaptic scaffold, thereby driving postsynaptic assembly.
Proteins that bind to MuSK or the AChR are likely to regu-
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late this mechanism. Activated MuSK contains several phos-
phorylated tyrosine residues in its cytoplasmic tail, which may
act as docking sites for signal transducing molecules (22). One
of these residues, a juxtamembrane tyrosine within an NPXY
consensus, is indeed required for agrin-induced AChR phospho-
rylation and clustering, suggesting the involvement of a PTB
(phosphotyrosine-binding) domain adaptor protein (23, 24). An-
other critical step in agrin’s signaling pathway are calcium
fluxes, as the fast chelator, BAPTA-AM, inhibits agrin-induced
AChR clustering (25). However, the nature of this calcium-de-
pendent step is unknown.
Moreover, several observations indicate the existence of a
critical kinase downstream of MuSK. Thus, staurosporine does
not affect agrin-induced activation of MuSK but inhibits AChR
b phosphorylation and AChR clustering, strongly suggesting
that a staurosporine-sensitive intermediate kinase down-
stream of MuSK causes AChR phosphorylation and aggrega-
tion (26). Such a kinase(s) may be one or several members of
the Src family, because Fyn and Fyk associate with AChRs in
the Torpedo electric organ (27), whereas Src (c-Src) and Fyn are
bound to AChRs in mammalian muscle (28). Furthermore, Src
can phosphorylate AChR b subunit fusion proteins (28), and
Src members are regulated by rapsyn when expressed in fibro-
blasts, causing AChR phosphorylation in this heterologous sys-
tem (29).
In several signaling pathways, the functional roles of Src
kinases are indicated by an increase in their kinase activities
following extracellular stimulation (30). Similarly to muscle,
Src family kinases associate with ionotropic neurotransmittor
receptors in the central nervous system, e.g. Src with NMDA
receptors and Lyn with AMPA receptors (31, 32). The associ-
ated kinases regulate receptor channel properties and form
receptor-bound signaling cascades, as shown for Lyn, which is
activated by AMPA stimulation of cerebellar neurons, leading
to activation of the mitogen-activated protein kinase pathway
and possibly synaptic plasticity (31).
To begin to understand the role of the Src family in postsyn-
aptic differentiation in muscle and in agrin-induced signaling
events downstream of MuSK, we examined the effect of agrin
on tyrosine phosphorylation of proteins associated with the
AChR, in particular the Src family members. We demonstrate
that agrin causes activation and phosphorylation of AChR-
bound Src class kinases, which requires rapsyn and correlates
with AChR phosphorylation and aggregation. Src-related ki-
nases thus cause AChR phosphorylation induced by agrin and
may play a role in AChR clustering, suggesting that the Src
family not only regulates ionotropic receptors channel proper-
ties but also contributes to the synaptic localization of these
receptors.
EXPERIMENTAL PROCEDURES
Cell Culture—Cell culture reagents were purchased from Life Tech-
nologies, Inc. C2 (C2C12) and S27 mouse muscle cells were maintained
at 37 °C in 8% CO2 and propagated in Dulbecco’s modified Eagle’s
medium with 4.5 g/liter D-glucose containing 20% fetal bovine serum,
0.5% chick embryo extract, 2 mM glutamine, and penicillin/streptomy-
cin. After reaching 90–100% confluence, cells were shifted to fusion
medium containing Dulbecco’s modified Eagle’s medium, 5% horse se-
rum, and 2 mM glutamine and fed daily. C2 myotubes were used for
experiments after 2 days in this medium, while S27 cells were used
after 2–3 days, by which time myotubes similar to C2 had formed. We
noticed that the morphology of the S27 myotubes varied between dif-
ferent experiments, in that myotubes were occasionally wider than in
C2 (see Fig. 8, S27 cells treated with 50 nM agrin). Furthermore, the
fusion of myoblasts to form myotubes was less efficient in the case of
S27, such that most cultures had more unfused cells than C2. Never-
theless, these morphological variations did not affect the outcome of our
experiments, because agrin-induced clustering of AChRs and phospho-
tyrosine-containing proteins, as well as phosphorylation of MuSK and
AChR-bound Src family kinases, were consistently absent in S27 cells
irrespective of their morphology. Rapsyn2/2 and the corresponding
wild-type myoblasts were grown at 33 °C, 5% CO2 in the same medium
as C2 cells with an additional 4 units/ml g-interferon, as described
previously (21). Confluent cultures were fed with C2 fusion medium
every second day and used for experiments after 3–4 days.
Antibodies—To detect AChR-associated phosphotyrosine proteins by
immunoblotting, we used a mixture of two commercially available
mouse monoclonal antibodies, 4G10 (Upstate Biotechnology, Lake
Placid, NY) and PY20 (Transduction Laboratories, Lexington, KY). The
mouse monoclonal antiserum 88B, reactive with the AChR g and d
subunits, was provided by Dr. S. C. Froehner (University of North
Carolina, Chapel Hill). Rat monoclonal antibodies 124 against the
AChR b subunit were a gift from Dr. J. Lindstrom (University of
Pennsylvania, Philadelphia). To detect Src-related kinases, we used
src-CT (Santa Cruz Biotechnology, Santa Cruz, CA), a rabbit polyclonal
antibody raised against the C terminus of Src (c-Src), which is highly
conserved in several Src-related kinases. Src-CT reacts with Src, Fyn,
Yes (28), and possibly further kinases of the Src family. Fyn was
detected by a rabbit polyclonal Fyn-specific antiserum (Santa Cruz
Biotechnology). The antiserum against MuSK was as described previ-
ously (26).
Expression of Agrin Constructs—To express soluble C-terminal agrin
forms, COS cells were grown at 37 °C in 8% CO2 using Dulbecco’s
modified Eagle’s medium, 10% fetal calf serum, 2 mM glutamine, and
penicillin/streptomycin. Cells were transfected with neural (4,8) or
muscle (0,0) agrin expression vectors (C-Ag12,4,8 and C-Ag12,0,0, respec-
tively), and the medium, containing soluble agrin, was collected for 3
days as described previously (26).
Isolation of AChR Protein Complexes and Immunoprecipitation—
Myotubes were lysed in a mild extraction buffer containing 1% Nonidet
P-40 and an abundance of protease and phosphatase inhibitors, and
AChRs were precipitated with a-bungarotoxin (a-BT) coupled to Sepha-
rose beads (a-BT-Sepharose beads) as described previously (21). Alter-
natively, AChRs were isolated using 200 nM soluble biotin-conjugated
a-BT followed by streptavidin-coupled agarose beads (Molecular
Probes, Eugene, OR), which gave identical results. As controls, an
excess (10 mM) of free a-BT was added, or unconjugated Sepharose was
used. To immunoprecipitate Src members representing the total cellu-
lar Src family pool, myotube extracts were incubated with 1 mg of
src-CT antibodies followed by protein A-Sepharose. Cellular MuSK was
isolated accordingly using polyclonal anti-MuSK antibodies and protein
A-Sepharose.
In Vitro Phosphorylation and Reprecipitation of Phosphotyrosine Pro-
teins and Src-related Kinases—To identify the 60-kDa AChR-associated
phosphoprotein, AChR protein complexes were precipitated as de-
scribed above. Complexes were dissociated by an incubation at 80 °C for
10 min in dissociation buffer containing 50 mM NaCl, 30 mM trietha-
nolamine, pH 7.5, 5 mM EDTA, 5 mM EGTA, 1% Triton X-100, 0.5%
SDS, 0.5% deoxycholate, 50 mM NaF, 3 mM sodium orthovanadate, 50
mM phenylarsine oxide, 10 mM p-nitrophenylphosphate and 1 mM phen-
ylmethylsulfonyl fluoride. After harsh vortexing and centrifugation, the
proteins released into the supernatant were reprecipitated with anti-
phosphotyrosine antibodies (4G10) covalently coupled to agarose beads
(Upstate Biotechnology). These precipitates were washed three times
with wash buffer (0.4% Triton X-100, 120 mM NaCl, 30 mM triethanol-
amine, pH 7.5, 5 mM EGTA, 5 mM EDTA, 2 mM sodium orthovanadate,
1 mM phenylmethylsulfonyl fluoride, 10 mM p-nitrophenylphosphate, 50
mM phenylarsine oxide, 50 mM NaF) and resuspended in SDS sample
buffer for SDS-PAGE and src-CT immunoblotting.
The kinase activity of AChR-associated Src family kinases was as-
sayed by incubating a-BT-Sepharose-precipitated AChR complexes for
10 min at 25 °C under phosphorylating conditions (kinase assay buffer:
20 mM Tris, pH 7.4, 10 mM MgCl2, 2 mM MnCl2, 1 mM phenylmethyl-
sulfonyl fluoride, 1 mM dithiothreitol, 1 mM sodium orthovanadate, 20
mCi of [g-32P]ATP). Reactions were stopped by the addition of kinase
wash buffer on ice (10 mM Tris, pH 7.2, 200 mM NaCl, 1 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate), and beads
were washed twice in this buffer. Complexes were dissociated by an
incubation for 10 min at 80 °C in phosphate-buffered saline, pH 7.4,
containing 1% Triton X-100, 0.5% SDS, 0.5% deoxycholate, 1 mM phen-
ylmethylsulfonyl fluoride, and 1 mM sodium orthovanadate. Src class
kinases were precipitated from supernatants using src-CT antibodies
and protein A-Sepharose followed by washing in dissociation buffer,
elution into SDS-PAGE sample buffer, SDS-gel electrophoresis, and
autoradiography.
For both methods, the quantitation of signals on films was performed
by scanning with a computerized densitometer (Nikon Scantouch 210)
and using the NIH Image J 1.04b software (National Institutes of
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Health, Bethesda, MD). Background signals, originating from control
precipitations including excess of free a-BT, were subtracted from a-BT
AChR precipitations. Values from untreated cells were set to 100%, and
signals after agrin treatment were calculated accordingly. Statistical
evaluation was performed by ANOVA followed by pairwise Bonferroni’s
t tests.
Tyrosine Kinase Inhibitors—To examine the effects of kinase inhib-
itors on tyrosine phosphorylation of proteins bound to the AChR, C2
myotubes were incubated for 5 to 6 h with 1–20 nM staurosporine
(Sigma), 1 mM herbimycin A (Life Technologies, Inc.), or carrier controls.
After stimulation with agrin, cells were extracted and analyzed by a-BT
AChR precipitation followed by phosphotyrosine immunoblotting.
Quantitation of signals was carried out as described previously (26).
Immunoblotting—To detect proteins in AChR, src-CT, or MuSK pre-
cipitations, proteins were eluted into SDS sample buffer, separated by
SDS-PAGE, and transferred to nitrocellulose. Membranes were probed
with the appropriate antibodies, and immunoreactive bands were visu-
alized using horseradish peroxidase-conjugated secondary antibodies
and enhanced chemiluminescence (ECL, Amersham Pharmacia Bio-
tech). For reprobing, blots were stripped by incubating them for 20 min
in 200 mM glycine, 0.1% Tween 20, pH 2.5.
Immunocytochemical Staining and Fluorescence Microscopy—To vi-
sualize the distribution of AChRs and phosphotyrosine proteins in C2
and S27 myotubes, cells were grown and fused on chamber slides (Nunc,
Life Technologies, Inc.) and treated for 15 h with agrin concentrations
ranging from 0.5 to 100 nM. Cells were incubated with 100 nM tetram-
ethylrhodamine-conjugated a-bungarotoxin (Molecular Probes) in fu-
sion medium for 1 h at 37 °C followed by fixation in methanol for 7 min
at 220 °C and permeabilization (5 min in phosphate-buffered saline
containing 1% Triton X-100 and 1 mM sodium orthovanadate). Phos-
photyrosine proteins were detected by PY20 antibodies (Transduction
Laboratories) and fluorescein isothiocyanate-conjugated goat-anti-
mouse secondary antisera (Jackson ImmunoResearch Laboratories, La
Roche, Switzerland) in the presence of 1 mM sodium orthovanadate.
Cells were mounted in glycerol containing p-phenylenediamine and
examined with a microscope (Axioskop 2, Carl Zeiss) equipped with the
appropriate fluorescence filters. Images were processed with a comput-
er-supported cooled 3CCD camera (Hamamatsu, Hamamatsu-City,
Japan).
RESULTS
Agrin Induces Tyrosine Phosphorylation of Several Proteins
Associated with the AChR—In our initial experiments, we an-
alyzed agrin-induced tyrosine phosphorylation of proteins as-
sociated with the AChR by preparing extracts from agrin-
treated and untreated C2 myotubes; AChRs were precipitated
with a-bungarotoxin (a-BT) covalently coupled to Sepharose
beads, or using biotinylated a-BT in combination with strepta-
vidin-agarose, followed by phosphotyrosine immunoblotting.
To assess nonspecific protein binding to the beads, free a-BT
was added prior to the precipitation, or unconjugated Sepharose
was used. Using this procedure allows the specific isolation of
AChRs in association with several postsynaptic proteins (21).
We stimulated C2 myotubes for increasing times with either
recombinant neural agrin (agrin 4,8) or the predominant agrin
isoform of muscle (agrin 0,0), which is much less effective in
aggregating AChRs (6, 33). a-BT precipitation and phosphoty-
rosine immunoblotting revealed a consistent pattern of AChR-
associated phosphotyrosine bands induced by neural but not
muscle agrin (Fig. 1). In addition to AChR-bound MuSK and
the AChR b subunit (26), we detected a band at about 70 kDa.
This protein appears to represent the AChR d subunit, based on
the cross-reactivity with d-specific antibodies in stripping and
reprobing experiments (Fig. 1). In addition, an AChR-associ-
ated protein of about 60 kDa, i.e. the molecular mass of Src
family kinases, consistently became tyrosine-phosphorylated
in response to neural agrin. Its increase in phosphorylation
occurred in parallel with that of AChR-bound MuSK and the
AChR b and d subunits, as it was first detected after a 15 min
treatment with 0.1 nM neural agrin and reached a peak after 40
min (Fig. 1). Dephosphorylation of this 60-kDa band strictly
paralleled that of the AChR subunits, as all three proteins were
still phosphorylated to an intermediate degree after a 15-h
treatment with neural agrin. MuSK, however, was no longer
phosphorylated after this time. In these assays, agrin-induced
tyrosine phosphorylation events were observed only for pro-
teins associated with the AChR and not when total cellular
lysates were analyzed without precipitation (Fig. 1, L lanes).
This selectivity indicates local, AChR-bound signaling, which
does not involve changes in phosphorylation on the level of a
whole myotube.
To determine whether this AChR-associated 60-kDa phos-
photyrosine protein represents one or several members of the
Src family, immunoblots were stripped and reprobed with pan-
Src antibodies (src-CT) that recognize Src, Fyn, and Yes in
muscle cells (28). These assays revealed that the protein indeed
comigrates precisely with AChR-bound Src members and that
the protein amounts of these associated kinases are not af-
fected by agrin (Fig. 2A). We have previously reported that two
members of the Src family, Src and Fyn, are associated with
AChRs and that they migrate with identical mobility in gel
electrophoresis and immunoblotting experiments (28). Further
reprobing studies using Fyn-specific antibodies confirmed that
the observed 60-kDa phosphotyrosine band indeed comigrates
with AChR-bound Fyn (Fig. 2B). The amounts of AChR-bound
Src and Fyn are unchanged by agrin (26), a finding similar to
the results using src-CT antibodies (Fig. 2A). Therefore, both
kinases are associated constitutively with the AChR independ-
ently of agrin, and either one or both of them may become
phosphorylated strictly in response to agrin.
AChR-associated Kinases of the Src Family Are Activated by
Neural Agrin—To confirm that the 60-kDa AChR-associated
phosphoprotein indeed represents one or several members of
the Src family bound to the AChR, we isolated large amounts of
FIG. 1. Neural agrin induces tyrosine phosphorylation of a
60-kDa protein associated with AChRs. C2 myotubes were treated
for up to 15 h with 0.1 nM neural (4,8) or muscle (0,0) agrin. AChRs were
isolated from cellular lysates using a-BT-Sepharose beads followed by
SDS-PAGE and phosphotyrosine immunoblotting (Tox-P/PY-blot).
Middle panel, the blot was stripped and reprobed with MuSK-specific
antibodies (Tox-P/MuSK-reprobe), whereas a second reprobing using
AChR g- and d-specific antisera (monoclonal antibodies 88b) is shown at
the bottom (Tox-P/g/d-reprobe). Controls for AChR precipitation in-
cluded the addition of 10 mM free a-BT (1T) and the use of unconjugated
Sepharose (C). The solid arrowheads indicate proteins associated with
AChRs isolated by a-BT precipitation. The open arrowhead designates
the AChR-bound protein(s) of ; 60 kDa in which tyrosine phosphoryl-
ation is induced by neural agrin. L indicates a fraction (0.3%) of the
initial lysate analyzed without precipitation.
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AChR protein complexes from agrin-treated and untreated C2
myotubes using a-BT-Sepharose. Complexes were dissociated
by an incubation at 80 °C in a buffer containing deoxycholate
and SDS. The proteins released were then reprecipitated with
phosphotyrosine antibody beads, immunoblotted, and probed
with src-CT antibodies. This assay specifically monitors the
overall levels of tyrosine phosphorylation of Src class kinases
bound to the AChR. We indeed found a significant increase in
the phosphotyrosine content of these kinases in response to
neural agrin (Fig. 3A). As Src members undergo autophospho-
rylation when activated, we additionally used kinase assays to
examine the effect of neural agrin on phosphate incorporation
into and thus activation of AChR-associated Src kinases. To
this end, a-BT-precipitated AChR complexes, isolated from
agrin-treated or untreated cells, were subjected first to in vitro
phosphorylation, using [g-32P]ATP at 25 °C. The complexes
were then dissociated at 80 °C and released Src members im-
munoprecipitated with src-CT antibodies followed by gel elec-
trophoresis and autoradiography. In these assays, neural agrin
significantly increased the phosphate incorporation into Src-
related kinases by ;3-fold, indicative of their activation (Fig.
3B). Together, these results show that one or several AChR-
associated kinases of the Src family are activated by neural
agrin and that the AChR-bound phosphotyrosine band at 60
kDa, as seen on immunoblots, indeed originates, at least in
part, from Src members.
Interestingly, when Src members were isolated from agrin-
treated myotubes by a direct immunoprecipitation with src-CT
antibodies, their phosphotyrosine content was unaffected in
comparison with untreated cells (Fig. 3C). Thus, agrin specifi-
cally activates those Src-related kinases that are associated
with AChRs without affecting the total cellular kinase pool.
Agrin-induced Phosphorylation of AChR-bound Src Members
Correlates with AChR Phosphorylation—We asked how activa-
tion of AChR-associated Src members correlates with phospho-
rylation of the AChR subunits and MuSK. For this purpose, C2
myotubes were treated for various times with a wide range of
agrin concentrations (20 pM-5 nM). A 5-min incubation with 0.5
nM neural agrin was sufficient to induce significant phospho-
rylation of AChR-bound Src family kinases and the receptor b
and d subunits, as well as of AChR-associated MuSK (Fig. 4).
Maximal phosphorylation of these proteins, particularly at
lower agrin concentrations, required a 40-min incubation with
neural agrin. At 20 pM agrin, a slight decrease in the extent of
Src family phosphorylation (relative to maximal stimulation at
higher concentrations) was paralleled by a decreased phospho-
tyrosine signal of the AChR b and d subunits. Muscle agrin had
no effect on any phosphorylation. Thus, phosphorylation of
AChR-bound Src-related kinases intimately correlates with
AChR b and d phosphorylation, raising the possibility that
AChR phosphorylation occurs in direct response to Src member
activation.
FIG. 2. Agrin increases tyrosine phosphorylation but not the
protein amount of AChR-bound Src class kinases. C2 myotubes
were treated with 0.1 nM (A) or 0.5 nM (B) neural agrin as indicated, and
cell lysates were subjected to precipitation with a-BT-Sepharose beads
and immunoblotting. Controls included the addition of 10 mM free toxin
(1T) and unconjugated Sepharose (C). A, phosphotyrosine immunoblot-
ting followed by reprobing with pan-Src antibodies (src-CT) reveals that
the 60-kDa phosphoprotein comigrates with Src family kinases (src’s).
B, a comparison of phosphotyrosine immunoblotting and reprobing with
Fyn-specific antibodies shows identical electrophoretic mobilities of the
agrin-induced 60-kDa phosphoprotein (src’s) and AChR-bound Fyn.
FIG. 3. Neural agrin specifically activates AChR-associated
Src-related kinases without affecting tyrosine phosphorylation
of the total cellular Src family pool. C2 myotubes were stimulated
with 0.5 nM agrin as indicated and lysed under mild conditions. A, cell
lysates were incubated with a-BT-Sepharose beads to isolate AChRs
including the addition of 10 mM free toxin as a control (1T). Precipitated
AChR protein complexes were dissociated in a buffer containing 0.5%
SDS and deoxycholate at 80 °C followed by reprecipitation with anti-
phosphotyrosine antibodies coupled to agarose beads (Re-IP PY-aga).
Phosphotyrosine contents of AChR-associated Src class kinases were
visualized by src-CT immunoblotting (left). Immunoblots from three
experiments were quantitated by densitometric scanning of films. After
subtracting the values of control precipitations (1T) from a-BT-precip-
itated samples, signals of untreated cells were set to 100% (control), and
signals after agrin treatment were calculated accordingly. Data repre-
sent the mean 6 S.D. (right). B, a-BT-precipitated AChR complexes
were subjected to in vitro phosphorylation (IVP), using phosphorylating
conditions and [g-32P]ATP at 25 °C, followed by dissociation as de-
scribed in A, reprecipitation with src-CT antibodies and protein A-
Sepharose (Re-IP src-CT), SDS-PAGE, and autoradiography (left). The
quantitation (right) shows the mean 6 S.D. from six experiments eval-
uated by densitometric scanning as described in A. C, Src-related ki-
nases were isolated from agrin-treated cells using src-CT antibodies
and protein A-Sepharose precipitation followed by phosphotyrosine im-
munoblotting. As controls, either the src-CT antibody (2Ab) or the
cellular lysate (2L) was omitted. *, differs significantly from control,
p , 0.05 (by ANOVA followed by Bonferroni’s t test).
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Staurosporine Selectively Blocks Agrin-induced Phosphoryl-
ation of AChR-associated Src Family Kinases and the
AChR—To analyze the role of Src family activation in agrin-
induced AChR phosphorylation and clustering, we used the
kinase inhibitors herbimycin and staurosporine. Both of these
inhibitors block AChR b subunit phosphorylation and AChR
aggregation (12, 13), whereas staurosporine does not affect
agrin-induced activation of MuSK (26). In this present study,
we observed that staurosporine inhibits agrin-induced phos-
phorylation of AChR-bound Src family kinases and of AChR b
and d subunits (Fig. 5A). Using increasing concentrations of
staurosporine, Src member phosphorylation was gradually re-
duced strictly in parallel with AChR phosphorylation (Fig. 5B).
Most dramatically, at 20 nM of staurosporine, agrin did not
induce significant phosphorylation of AChR-associated Src
members and AChR b and d subunits, whereas phosphoryla-
tion of MuSK bound to the AChR occurred normally. Thus,
MuSK activation can be uncoupled from phosphorylation of Src
kinases and the AChR, suggesting that the AChR b and d
subunits are direct substrates for AChR-bound Src members
but not for MuSK.
Herbimycin, in contrast, abolished phosphorylation of all
proteins seen in a-BT-precipitates, including MuSK, Src ki-
nases, and the AChR (Fig. 5A). Together, these results demon-
strate that herbimycin and staurosporine exert their inhibitory
effect on AChR phosphorylation and clustering by interfering
with distinct steps in the agrin signaling pathway. Whereas
herbimycin inhibits MuSK, staurosporine blocks autophospho-
rylation of AChR-bound Src kinases, suggesting that Src acti-
vation is downstream of MuSK and involved in AChR
clustering.
In the Absence of Rapsyn, AChR-bound Src Members Are Not
Activated by Agrin—To further correlate Src family autophos-
phorylation with AChR clustering, we analyzed the effect of
neural agrin on tyrosine phosphorylation of AChR-bound pro-
teins in rapsyn-deficient myotubes. These cells were derived
from rapsyn knockout mice and do not aggregate AChRs in
response to agrin (21). Agrin induces normal phosphorylation
of total cellular as well as AChR-associated MuSK in these
cells, whereas AChR b subunit phosphorylation is strongly
reduced, suggesting that rapsyn is required for a step down-
stream of MuSK that leads to AChR phosphorylation and clus-
tering (20, 21).
Therefore, we examined phosphorylation of AChR-bound Src
members by agrin in rapsyn 2/2 myotubes. In control wild-
type cells, agrin induced phosphorylation of AChR-bound Src
family kinases and the AChR b and d subunits as in C2 myo-
tubes (Fig. 6). In contrast, in the rapsyn-deficient myotubes,
these phosphorylations were strongly reduced in both agrin-
treated and untreated cells. Control experiments confirmed
that rapsyn-deficient and wild-type cells express identical lev-
els of MuSK and Src members and that the amount of a-BT-
isolated AChR is indistinguishable (Fig. 6; Ref. 21). These
results concur with those on staurosporine in C2 myotubes,
demonstrating that rapsyn is required for agrin-induced phos-
phorylation of AChR-bound Src family kinases and that this
activation occurs downstream of MuSK. The data further sug-
gest that AChR b and d subunits are direct substrates for these
Src class kinases.
In S27 Myotubes, Agrin Fails to Cause Phosphorylation of
AChR-bound Src Family Kinases—As a final correlation be-
tween agrin-induced Src member activation and AChR cluster-
ing, we analyzed Src class phosphorylation in S27 myotubes,
genetic variants of C2 defective in heparan and chondroitin
FIG. 4. Correlation between agrin-induced phosphorylation of
AChR-bound Src kinases and AChR subunits. C2 myotubes were
treated with neural (4,8) or muscle (0,0) agrin as indicated, and AChR
protein complexes were precipitated with a-BT-Sepharose followed by
phosphotyrosine immunoblotting (Tox-P/PY-blot). The bottom panel is
a short exposure (Short exp.) of the blot to better visualize the dose
dependence and time course of AChR b phosphorylation.
FIG. 5. Effects of tyrosine kinase inhibitors on agrin-induced
phosphorylation of AChR-bound MuSK, Src family kinases, and
the AChR b and d subunits. A, C2 myotubes were treated for 5 h with
1 mM herbimycin (H), the indicated concentrations of staurosporine (S),
or a Me2SO carrier control (c) and were then stimulated for 40 min with
1 nM neural agrin. Lysates were processed by a-BT-Sepharose precipi-
tation and subjected to phosphotyrosine immunoblotting. The lower
panel shows a shorter exposure (Short exp.) of the blot to better illus-
trate tyrosine phosphorylation of the AChR b subunit. B, four experi-
ments as shown in A were quantitated by densitometric scanning.
Relative intensities of phosphorylation of AChR-bound MuSK, Src
members, and AChR subunits from cells not treated with agrin were set
to 0%. Agrin-induced signals of cells incubated with carrier and lacking
staurosporine were set to 100% (control), and intensities of signals from
staurosporine-treated cells were calculated accordingly. The data are
shown as the mean 6 S.D.
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sulfate proteoglycan biosynthesis (34, 35). In these cells, even
high concentrations of agrin up to 100 nM do not induce AChR
clustering and b phosphorylation (10, 12).
To determine which step in the agrin signaling pathway is
affected in S27 cells, we examined agrin-induced phosphoryla-
tion and clustering events in these cells. In C2, 0.5 nM neural
agrin was sufficient to induce abundant co-clustering of AChRs
and phosphotyrosine proteins, as observed by double-label im-
munofluorescence microscopy using rhodamine-conjugated
a-BT and phosphotyrosine antibodies (Fig. 8). The same agrin
concentration also caused phosphorylation of AChR-bound
MuSK, Src family kinases and the AChR b and d subunits in C2
cells (Fig. 7A, see also Fig. 4). In contrast, in S27 myotubes, 50
and 100 nM agrin did not induce comparable phosphorylation of
any of these proteins, even though Src family kinases were
associated normally with the AChR and AChRs were present in
normal amounts (Fig. 7A). Similarly, 100 nM neural agrin failed
to induce the clustering of AChRs and phosphotyrosine-con-
taining proteins in these cells (Fig. 8). Some aggregates of
phosphotyrosine-containing proteins were occasionally ob-
served in agrin-treated S27 cells, but these were much smaller
and less intense than the typical clusters in C2 (Fig. 8).
Based on the absence of agrin-activated AChR-associated
MuSK in S27, we examined phosphorylation of the total cellu-
lar pool of MuSK by neural agrin in these cells, using MuSK
immunoprecipitation followed by phosphotyrosine immuno-
blotting. 100 nM neural agrin did not cause prominent MuSK
activation in S27, whereas in C2 cells, 0.5 nM caused a strong
phosphorylation (Fig. 7B). We noticed that the majority of
MuSK isolated from S27 cells migrated with a lower molecular
weight than in C2, consistent with defective glycosylation of
MuSK in the mutant cells. Our phosphotyrosine blotting as-
says, however, sometimes revealed weak agrin-induced phos-
phorylation of a MuSK population with the same apparent
molecular weight as in C2 (Fig. 7B). It is therefore possible that
MuSK exists in several forms in S27 cells, because of differen-
tial glycosylation, and that some of these subpopulations react
slightly differently to treatment with high doses of agrin. To-
gether, these experiments show that even high concentrations
of agrin fail to cause clustering of AChRs and phosphorylation
of AChR-bound Src members in S27. Although we cannot ex-
clude the possibility that further, unknown genetic defects in
these cells prevent AChR clustering, our results are consistent
with the assumption that, similar to herbimycin-treated C2
cells, MuSK is not activated by agrin in S27 cells, which causes
defects in the activation of AChR-bound Src family kinases, in
AChR phosphorylation, and in clustering of AChRs and phos-
photyrosine-containing proteins.
DISCUSSION
In this study, we demonstrate that agrin activates Src family
kinases that are associated with the AChR. The activation
occurs downstream of MuSK, requires rapsyn, and correlates
closely with agrin-induced AChR clustering. These data indi-
cate that Src family kinases are part of a local AChR-bound
signaling cascade and that they may play a role in the assembly
of AChR protein complexes into a postsynaptic apparatus.
Activation of Src Family Kinases by Agrin—Several of our
FIG. 6. In rapsyn-deficient myotubes, neural agrin does not
cause phosphorylation of AChR-bound Src members and AChR
b and d subunits. Rapsyn 2/2 and wild-type (W.T.) myotubes were
treated with 1 nM neural (4,8) or muscle agrin (0,0) as indicated and
analyzed by a-BT-Sepharose precipitation followed by phosphotyrosine
immunoblotting. A shorter exposure of the film revealed strong agrin-
induced AChR b phosphorylation in the wild type and no signal at all in
mutant cells (not shown). Src family kinases (src’s) were identified by
stripping and reprobing the blot with src-CT antibodies (lower panel).
The amounts of a-BT-isolated AChRs were equal between the two cell
types (not shown).
FIG. 7. Agrin fails to activate AChR-bound Src family kinases
in S27 myotubes. A, S27 and C2 myotubes were treated with neural
(4,8) or muscle agrin (0,0) as indicated. AChRs were isolated with
biotinylated a-BT followed by streptavidin-agarose precipitation and
phosphotyrosine immunoblotting. As controls, an excess (10 mM) of free
toxin was added (1T). To ensure equal amounts of a-BT-precipitated
AChRs and AChR-bound Src family kinases, parallel cells were sub-
jected to a-BT precipitation and AChR b subunit or src-CT immuno-
blotting (middle and bottom). For comparison, fractions (L) of the initial
lysate were loaded. B, cells treated with agrin as indicated were lysed
and processed by MuSK immunoprecipitation and phosphotyrosine im-
munoblotting (top). As a control, the MuSK antibody was omitted
(2Ab). To compare the amounts of MuSK between both cell types,
fractions of cellular lysates (L) were analyzed by MuSK immunoblotting
(bottom). The majority of MuSK (solid arrowheads) migrates with a
lower molecular weight in S27 than in C2 cells. A fragment of the MuSK
antibody that comigrates with the majority of MuSK in S27 cells is
denoted by the asterisk; the open arrowhead indicates phosphorylation
of a minor population of MuSK in S27 that migrates as in C2.
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observations indicate that AChR-associated kinases of the Src
family are activated by agrin. In agrin-treated myotubes, the
phosphotyrosine content of these kinases is increased, as
shown by both kinase reprobing and phosphotyrosine reprecipi-
tation experiments. Furthermore, in kinase assays in vitro,
incorporation of phosphate into the kinases is augmented by
agrin. Such in vitro phosphorylation assays are widely used to
analyze the activation of Src class kinases in response to var-
ious stimuli, e.g. growth factors, and an increase in phosphate
incorporation indicates kinase autophosphorylation and thus
activation (30). We can exclude the possibility that AChR-
bound Src family kinases are phosphorylated by MuSK, be-
cause staurosporine blocks Src phosphorylation without affect-
ing MuSK autophosphorylation (see also below). Thus, our
kinase assays most likely reflect Src family autophosphoryla-
tion. In our experiments, we used a high affinity Src family
antibody against a conserved epitope of Src, Fyn, and Yes. As
both Src and Fyn have been shown to be associated with AChRs
(28), we therefore assume that either one or both of these
kinases are activated by agrin. The affinities of specific anti-Src
or anti-Fyn antibodies in immunoprecipitations were too low to
show an activation of the respective individual kinase.2
Kinases of the Src family are regulated in complex ways,
both by tyrosine phosphorylation and by intramolecular pro-
tein interactions mediated by their SH2 and SH3 domains (30,
36). Activation can be achieved by binding of proline-rich se-
quences of other proteins to the SH3 domain, by interaction of
external phosphotyrosine peptides with the SH2 domain, or by
C-terminal dephosphorylation, all of which lead to the active
open Src conformation (36, 37). In all cases, activation requires
autophosphorylation of a tyrosine in the activation loop of the
kinase domain.
Based on these mechanisms, our observed Src family activa-
tion does not appear to be mainly mediated by C-terminal
dephosphorylation but rather by interacting proteins that bind
to the Src family SH2 and/or SH3 domains, thereby leading to
the increase in overall phosphotyrosine content. A good candi-
date for such an interacting protein is MuSK, a portion of
which is associated with the AChR and becomes phosphoryl-
ated in response to agrin (26). Interestingly, the cytoplasmic
domain of MuSK contains two proline-rich regions, one of
which corresponds to the consensus requirements for Src SH3
binding, as it contains the typical PXXP motif preceded by a
leucine (38, 39). These MuSK peptide motifs and/or the auto-
phosphorylated cytoplasmic tyrosine residues of activated
MuSK (22) could thus bind to Src class kinases causing kinase
opening, autophosphorylation, and activation. Such a mecha-
nism would work most efficiently and rapidly if the proteins
involved (AChRs, MuSK, and Src family kinases) were to form
a preassembled complex. Indeed, we have previously demon-
strated that these proteins interact in myotubes, before the
addition of agrin (21), and data in this study indicate that Src
family activation occurs rapidly, as early as 5 min after addi-
tion of agrin, and is highly correlated with the activation of
MuSK.
Src family activation was observed only for that fraction of
kinases associated with AChRs but not on the level of the total
cellular kinase pool. In contrast, the activation of Src members
in other signaling systems, such as mitogenic responses to
growth factors or adhesion on fibronectin, involves and is de-
tectable on the whole cellular kinase pool (40, 41). This illus-
trates an important difference between Src family signaling in
cell proliferation or adhesion and in postsynaptic assembly.
The latter process requires correct protein interactions, pre-
sumably driven by local signaling events, and would be hard to
reconcile with signaling occurring throughout myotubes as a
whole. The need for local signaling, combining kinase activa-
tion with protein interactions, is illustrated by MuSK, which,
in addition to signaling, also mediates protein interactions
involving its extracellular domain, and where, unlike in the
case of growth factor receptors, the activated kinase domain is
not sufficient to reproduce all aspects of signaling (20, 42).
Src Family Activation and AChR Phosphorylation—Our
AChR precipitation procedure combined with phosphotyrosine
immunoblotting also revealed agrin-induced phosphorylation
of AChR d subunits, which has been described previously in the
chick (43). Our present data are the first report of this modifi-
cation in mammalian myotubes, and they indicate that AChR d
phosphorylation caused by agrin highly correlates with AChR
clustering. Thus, neural but not muscle agrin induces both
phosphorylation and aggregation. Furthermore, herbimycin
and staurosporine inhibit both agrin-induced AChR clustering
and d phosphorylation, and phosphorylation of d is not observed
in rapsyn2/2 and S27 myotubes in which AChRs are not
clustered by agrin. As it reaches a peak after 40 min of agrin
treatment, AChR d phosphorylation may play a role early in
agrin-induced clustering and compensate for phosphorylation
of AChR b subunits, allowing agrin-induced clustering of mu-
tated AChRs lacking b cytoplasmic tyrosine residues (14). Be-
cause phosphorylated AChR d subunits bind to the adaptor
molecule Grb2 in the Torpedo electric organ (44), one role of d
phosphorylation in the agrin signaling pathway in myotubes
may be to recruit Grb2 to AChRs, thereby linking further
signaling pathways to the AChR. Colledge and Froehner (44)
have speculated that such an interaction may have to be of low
affinity, which fits our observed low relative extent of d phos-
phorylation. In fact, one intriguing possibility is that agrin-
induced b phosphorylation, which is of high relative stoichiom-
etry, regulates the channel properties of the AChR such that
clustered receptors have accurate desensitization kinetics,
whereas agrin-induced d phosphorylation regulates the associ-
ation of AChRs with signaling pathways, thereby facilitating
postsynaptic assembly.
Which tyrosine kinase phosphorylates the AChR in response
to agrin? Several of our experiments suggest that both the
AChR b and d subunits are direct substrates for agrin-acti-
vated Src members bound to the AChR but not for MuSK. First,2 C. Fuhrer, unpublished observations.
FIG. 8. Agrin induces co-clustering of AChRs and phosphoty-
rosine-containing proteins in C2 but not in S27 myotubes. C2
and S27 myotubes were treated for 15 h with the indicated concentra-
tions of neural agrin. Cells were double-labeled for AChRs with rho-
damine-conjugated a-BT (left panels) and for phosphotyrosine proteins
using anti-phosphotyrosine antibodies followed by fluorescein isothio-
cyanate-coupled secondary antisera (right panels). Whereas 0.5 nM of
agrin induces pronounced co-clustering of AChRs and phosphotyrosine-
containing proteins in C2, no comparable protein aggregates are ob-
served in S27 myotubes, not even at 100 nM of agrin. Scale bar, 20 mm.
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phosphorylation of Src members and of AChRs are strictly
correlated over a wide range of agrin concentrations and incu-
bation times. Second, staurosporine inhibits Src family activa-
tion, which intimately correlates with reduced AChR b and d
phosphorylation, whereas MuSK is unaffected. Third, stauro-
sporine is known to inhibit both tyrosine kinase autophospho-
rylation and phosphorylation of their direct substrates in par-
allel, as shown in the case of the insulin receptor and its
substrate IRS-1 and TrkA and its substrate phospholipase C-g1
(45, 46). Finally, the differential effect of herbimycin, which
also inhibits MuSK, versus staurosporine suggests a hierarchy
of phosphorylation, where MuSK activation is upstream of the
activation of AChR-bound Src kinases, which phosphorylate
the AChR b and d subunits.
Interestingly, as in staurosporine-treated C2 myotubes,
agrin-induced Src member activation and AChR phosphoryla-
tion are also inhibited in rapsyn-deficient cells, showing that
rapsyn is necessary for Src family activation by agrin. In fibro-
blasts, rapsyn interacts with and activates both MuSK and Src
members, causing AChR b and d phosphorylation (29, 47).
These previous findings and our present studies suggest a
complex of the AChR in association with rapsyn, MuSK, and
Src family kinases, in which rapsyn holds AChR-bound MuSK
and Src members in a conformation that allows activation of
Src kinases by MuSK. The latter scenario could occur via an
interaction of MuSK sequences with the Src family SH2 or SH3
domains as mentioned earlier. Src members thus appear to
phosphorylate the AChR in response to agrin, a process that
occurs downstream of MuSK and requires rapsyn.
Agrin-induced Src Family Activation and Postsynaptic Dif-
ferentiation—Studies in several signaling systems show that
an activation of Src family kinases by extracellular stimuli is
an indication of a functional role of these kinases in the respec-
tive pathways (30). In our case, the activation of AChR-bound
Src family kinases by agrin correlates closely with agrin-in-
duced AChR clustering as judged by several criteria, including
the differential effects of neural and muscle agrin, the inhibi-
tion by staurosporine and herbimycin, and the absence of
agrin-induced Src member activation and AChR clustering in
rapsyn-deficient myotubes. Furthermore, also in S27 myotubes
treated with high concentrations of agrin, AChR clustering and
phosphorylation of AChR-bound Src members are not observed
(Table I). As staurosporine blocks Src family but not MuSK
autophosphorylation, AChR-associated Src class kinases in-
deed appear to be the previously proposed kinase(s) down-
stream of MuSK that are important for AChR clustering (26).
Furthermore, by inference, Src family activation shows the
same dose dependence on neural agrin as AChR clustering,
because it correlates strictly with AChR b phosphorylation,
which, in turn, highly correlates with AChR aggregation (12).
Together, these striking correlations suggest that AChR-asso-
ciated Src family kinases play a role in agrin-induced postsyn-
aptic differentiation, to which AChR phosphorylation itself
may contribute.
Agrin-activated Src class kinases could act at different steps
in the pathway leading from muscle innervation to formation of
a fully differentiated postsynaptic apparatus. We have previ-
ously suggested that preassembled protein complexes contain-
ing AChRs in association with postsynaptic elements may be
the building blocks for agrin-induced formation of the postsyn-
aptic membrane (21) and that this mechanism involves a rapsyn-
dependent link of such complexes to the MuSK-based primary
synaptic scaffold (20). Preassembled AChR complexes contain
rapsyn, Src members, and MuSK, and signaling by these ki-
nases may render the complexes competent for such a link by
the phosphorylation of parts of the complexes and/or further
proteins. This mechanism could involve tyrosine phosphoryla-
tion of rapsyn, as rapsyn is a substrate for Src family kinases
when coexpressed in fibroblasts (29). However, in preliminary
experiments we did not observe tyrosine phosphorylation of
AChR-bound rapsyn due to agrin,3 although small amounts of
phosphorylation may have remained undetected.
Alternatively, as AChR-associated Src class kinases, in con-
trast to MuSK, are still activated after prolongated incubation
with agrin in vitro, they may play a role in growth and stabi-
lization of postsynaptic protein clusters. Interestingly, besides
rapsyn, several cytoskeletal proteins concentrated at the neu-
romuscular junction or in Torpedo synaptic membranes, in-
cluding talin, paxillin, and a-fodrin (1, 48), are known sub-
strates for Src class kinases (30). Talin and paxillin are also
found at focal adhesion sites, which have similarities to the
postsynaptic apparatus. In both cases, large protein complexes
mediating cell-cell contact are assembled by tyrosine kinase
signaling (49). Moreover, integrins, which modulate agrin sig-
naling, are found at both structures (50). Together, these sim-
ilarities suggest that AChR-associated Src family kinases may
contribute to postsynaptic assembly in a way analogous to their
proposed role in focal adhesion site assembly, by phosphoryl-
ating additional proteins, including cytoskeletal elements, and
thereby stabilizing growing AChR aggregates.
Finally, maturation of the postsynaptic apparatus involves a
series of cytoskeletal rearrangements, which ultimately lead to
formation of postsynaptic folds, including segregation of sev-
eral postsynaptic proteins between crests and troughs (51). At
the mammalian neuromuscular junction, as well as in Torpedo
electrocytes, tyrosine phosphorylation in the postsynaptic
membrane increases during this late stage of synaptic matu-
ration (52, 53). This activity could originate from AChR-bound
tyrosine kinases, e.g. Src members, and may cause correct
3 M. Moransard and C. Fuhrer, unpublished observations.
TABLE I
Activation of AChR-bound Src family kinases by agrin correlates with AChR clustering
For analysis of phosphorylation, C2, rapsyn2/2, and S27 myotubes were incubated for 40 min with neural (4,8) or muscle (0,0) agrin at
concentrations of up to 100 nM. In the case of staurosporine and herbimycin, inhibitors were added to cells 5–6 h prior to agrin treatment. AChRs
were isolated from cell extracts by a-BT precipitation, and phosphorylation of receptor-associated proteins (MuSK, Src-related kinases) and AChR
subunits was assayed by phosphotyrosine immunoblotting. For AChR clustering, myotubes were treated for 15 h with up to 100 nM agrin followed
by staining with rhodamine-conjugated a-BT and analysis by fluorescence microscopy (see also Refs. 12 and 21).
Cells/treatment
Phosphorylation AChR
clusteringMuSK Src’s AChR b AChR d
C2 2 agrin 2 2 2 2 2
C2 1 agrin 0,0 2 2 2 2 2
C2 1 agrin 4,8 1 1 1 1 1
C2 1 agrin 4,8 1 staurosporine 1 2 2 2 2
C2 1 agrin 4,8 1 herbimycin 2 2 2 2 2
Rapsyn2/2 1 agrin 4,8 1 2 2 2 2
S27 1 agrin 4,8 2 2 2 2 2
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colocalization of proteins like utrophin or syntrophin isoforms
with AChRs at the crests of the folds, whereas other proteins,
such as sodium channels or dystrophin, are enriched in the
troughs (51, 54). Indeed, some of these proteins as well as
dystrobrevin isoforms, which may also be differentially distrib-
uted, are tyrosine-phosphorylated in Torpedo or have tyrosine
phosphorylation consensus sites (51, 55). Thus, Src family-
mediated phosphorylation of such proteins may determine
their precise postsynaptic localization with respect to AChRs
and contribute to later aspects of postsynaptic maturation.
In the central nervous system, the Src family is thought to
have various functions, including regulation of glutamate re-
ceptors. At central synapses, NMDA receptors are regulated by
tyrosine phosphorylation and associated with Src (c-Src) in a
manner similar to muscle AChRs (56). In CA1 pyramidal cells
of rat hippocampus, Src activation induces long-term potenti-
ation, apparently by potentiation of bound NMDA receptors
(32). AMPA receptors of the cerebellum, on the other hand,
interact with the Src family kinase Lyn, which is activated
following receptor stimulation (31). Glutamate receptors thus
associate with Src members, which, upon activation, contribute
to synaptic plasticity in various ways. Compared with these
studies, our findings are the first indication that activation of
Src class kinases may also regulate the distribution and
postsynaptic localization of ionotropic neurotransmittor
receptors.
In summary, the present data, together with our previous
studies (21), suggest a model for AChR clustering in which
agrin activates AChR-bound MuSK, which requires rapsyn to
activate receptor-associated Src members, which phosphoryl-
ate AChR b and d subunits and possibly further proteins in the
vicinity. This AChR-bound signaling cascade causes preas-
sembled AChR protein complexes containing rapsyn, tyrosine
kinases, and postsynaptic proteins to be linked to a primary
synaptic scaffold formed by MuSK (20), thereby providing a
stepwise assembly mechanism of the postsynaptic apparatus.
In addition, Src kinases may contribute to the stabilization and
further differentiation of the postsynaptic apparatus, by phos-
phorylating cytoskeletal proteins, thereby modifying associa-
tions between the postsynaptic membrane and the cytoskele-
ton. Under several different experimental conditions,
therefore, Src phosphorylation and activation are correlated
with AChR clustering, and the precise role of Src family ki-
nases in postsynaptic assembly remains to be investigated.
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